|1.||Bryzgalov, A O: 1 article (07/2005)|
|2.||Sorokina, I V: 1 article (07/2005)|
|3.||Ganenko, Iu A: 1 article (07/2005)|
|4.||Tolstikova, T G: 1 article (07/2005)|
|5.||Zhukova, N A: 1 article (07/2005)|
|6.||Dolgikh, M P: 1 article (07/2005)|
|7.||Volkova, E B: 1 article (07/2005)|
|1.||Cardiac Arrhythmias (Arrythmia)
07/01/2005 - "Pretreatment of the experimental animals with alaglyzin in a dose of 0.25 mg/kg prevented from the arrhythmia development in both tests, while a dose of 0.125 mg/kg was effective only in the CaCl2, test."
07/01/2005 - "The activity of alaglyzin, a new drug based on a clathrate complex of allapinine (well-known antiarrhythmic) with glycyrrhizic acid (GA), was studied on the models of arrhythmia induced by itraperitoneal injections of calcium chloride (CaCl2) and adrenaline (epinephrine) in rats. "
|1.||Glycyrrhizic Acid (Glycyrrhizin)
|3.||Calcium Chloride (Calcium Chloride, Anhydrous)